Clinical Trial

A Study of Adaptive Radiotherapy of Head-neck Cancer Using Daily Replanning and Optimization of the Treatment Plan.

Study acronym: DART-HN
Recruiting
View on ClinicalTrials.gov →
Summary
Radiotherapy of head-neck cancer is associated with significant side effects. Using daily online adaptive radiotherapy to account for the changing anatomy, radiation to organs at risk can be lowered. We will investigate whether this is feasible and associated with a reduction in the risk of toxicity.
Trial Details
NCT Number NCT07506902
Lead Sponsor Rigshospitalet, Denmark
Conditions Head & Neck Squamous Cell Carcinoma
Enrollment 40 participants
Start Date 2023-11-21
Primary Completion 2027-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-02